N@N

MYGN, KND, RHB, RGA, AGP. Top Gainers With Lowest Price Friction In Morning Trade Today

^{Published on 2009-06-17 08:28:49, Last Modified on 2010-12-22 14:14:33 - WOPRAI}
 

June 17, 2009 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for June 17, 2009. Since late October market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This fair market making requirement is designed to prevent market makers from manipulating stock prices. Here is a list of the top companies with the largest gains this morning and lowest price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Myriad Genetics (NASDAQ: MYGN), Kindred Healthcare (NYSE: KND), Rehabcare Group (NYSE: RHB), Reinsurance Group of America (NYSE: RGA) and AMERIGROUP (NYSE: AGP). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

Symbol Change % BuyVol Buy% SellVol Sell% NetVol Friction

MYGN $1.09 3.13% 46,504 42.36% 38,277 34.87% 8,227 75

ERY $1.03 5.23% 327,121 51.19% 306,604 47.98% 20,517 199

KND $0.93 8.47% 51,619 60.15% 22,477 26.19% 29,142 313

RHB $0.88 4.35% 15,290 68.60% 4,600 20.64% 10,690 121

RGA $0.83 2.44% 22,071 49.23% 12,765 28.47% 9,306 112

AGP $0.68 2.45% 14,996 55.86% 8,840 32.93% 6,156 91

Click here to view chart:

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar gains (Change) and very low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows MYGN with a dollar gain today of +$1.09 and a Friction Factor of 75 shares. That means that it only takes 75 more shares of buying than selling to move MYGN higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

Myriad Genetics, Inc. (NASDAQ: MYGN), a healthcare company, engages in the development and marketing of molecular diagnostic and therapeutic products. Its products include BRACAnalys for assessing a woman�s risk for breast and ovarian cancer; COLARIS molecular for assessing a person�s risk of developing colorectal cancer or uterine cancer; COLARIS AP, a molecular diagnostic product for colon cancer that detects mutations in the APC and MYH genes; MELARIS, which analyzes mutations in the p16 gene to determine genetic susceptibility to malignant melanoma, a skin cancer; and THERAGUIDE 5-FU that analyzes mutations in the DPYD gene and variations in the TYMS gene to assess patient risk of 5-FU toxicity and guides physician dosing decisions. The company markets its products through its own sales force in the United States and through marketing collaborations internationally. It is also developing Azixa, a phase II drug candidate for solid primary and metastatic brain tumors; Vivecon, a phase I preclinical drug candidate for AIDS; MPC-2130, a phase I drug for hematologic cancers; MPC-3100, a late stage preclinical drug for the treatment of cancer; and MPC-0920, a phase I drug for thrombosis. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.

Kindred Healthcare, Inc. (NYSE: KND) operates as a healthcare services company in the United States. It operates in three divisions: Hospital, Health Services, and Rehabilitation. The Hospital division operates long-term acute care hospitals that provide outpatient services, including diagnostic services, rehabilitation therapy, CT scanning, one-day surgery, laboratory, and X-ray. The Health Services division operates nursing centers, which offer long-term care services; a range of pharmacy, medical, and clinical services; and routine services, including daily dietary, social, and recreational services. This division also provides specialized programs for residents suffering from Alzheimer�s disease and other dementias through its reflections units. The Rehabilitation division provides contract therapy services, including physical, occupational, and speech therapies to residents and patients of nursing centers, assisted living facilities, and hospitals. This division also offers specialized care programs to address dementias and Alzheimer�s disease, wound care, pain management, and pulmonary rehabilitation therapies, as well as fall prevention and continence improvement. Its rehabilitation services also include therapy record completion and documentation review, clinical audit processes, updates regarding regulatory changes, and clinical care strategies. As of December 31, 2008, the company operated 82 long-term acute care hospitals with 6,482 licensed beds in 24 states; and 228 nursing centers with 28,525 licensed beds in 27 states. Kindred Healthcare was founded in 1998 and is headquartered in Louisville, Kentucky.

RehabCare Group, Inc. (NYSE: RHB) provides rehabilitation program management services in hospitals, skilled nursing facilities, outpatient facilities, and other long-term care facilities in the United States. The company also offers post-acute program management, medical direction, physical therapy rehabilitation, quality assurance, compliance review, specialty programs, and census development services. It operates in three segments: Program Management Services, Hospitals, and Other Healthcare Services. The Program Management Services segment provides acute rehabilitation units for conditions, such as strokes, orthopedic conditions, and head injuries; skilled nursing units for conditions, such as stroke, cancer, heart failure, burns, and wounds; and outpatient therapy programs for hospital-based and satellite programs. This segment also offers contract therapy, including rehabilitation services in freestanding skilled nursing, long-term care, and assisted living facilities for neurological, orthopedic, and other medical conditions. The Hospitals segment operates rehabilitation hospitals, which provide intense interdisciplinary rehabilitation services to patients on an inpatient and outpatient basis; and long-term acute care hospitals that provide therapeutic and clinical care to patients with medically complex diagnoses requiring a longer length of stay than 25 days. The Other Healthcare Services segment provides strategic and financial consulting services, and therapist and nurse staffing services for healthcare providers. The company owns and operates five long-term acute care hospitals and six rehabilitation hospitals. RehabCare Group was founded in 1982 and is headquartered in St. Louis, Missouri.

Reinsurance Group of America, Incorporated (NYSE: RGA), through its subsidiaries, engages in individual and group life, asset-intensive, critical illness, and financial reinsurance in the United States, Canada, Europe, South Africa, and the Asia Pacific. The company provides insurers with reinsurance of traditional life insurance products, including term life, credit life, universal life, whole life, joint and last survivor insurance, and critical illness, as well as annuities, financial reinsurance, and direct premiums, which include single premium pension annuities, universal life, and group life. It also offers reinsurance for mortality, morbidity, lapse risks, and investment-related risks. The company was founded in 1973 and is headquartered in Chesterfield, Missouri. Reinsurance Group of America, Incorporated (NYSE: RGA) operates independently of GenAmerica Financial, LLC as of September 12, 2008.

AMERIGROUP Corporation (NYSE: AGP) operates as a multistate managed healthcare company focused on serving people, who receive healthcare benefits through publicly sponsored programs, such as Medicaid, Children�s Health Insurance Program (CHIP), Medicaid expansion programs, and Medicare Advantage. Its Medicaid program makes federal matching funds available to various states for the delivery of healthcare benefits to eligible individuals, as well as allows each state to establish its own eligibility standards, benefits package, payment rates, and program administration under broad federal guidelines. The company also offers CHIP, a federal and state funded program that provides healthcare coverage to children covered by Medicaid or other insurance programs; Temporary Assistance to Needy Families, a program that provides assistance to low-income families with children; and Supplementary Security Income, a federal income supplement program, which provides assistance to aged, blind, and disabled individuals who have little or no income. In addition, AMERIGROUP Corporation provides FamilyCare, a Medicaid expansion health insurance program created to help uninsured families, single adults, and couples without dependent children obtain affordable healthcare coverage. It provides its healthcare services through contracts with primary care physicians, specialists, hospitals, and ancillary providers. As of December 31, 2008, the company provided an array of products to approximately 1,579,000 members in Florida, Georgia, Maryland, New Jersey, New Mexico, New York, Ohio, South Carolina, Tennessee, Texas, and Virginia. The company was formerly known as AMERICAID Community Care. AMERIGROUP Corporation was founded in 1994 and is headquartered in Virginia Beach, Virginia.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2,550,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month�s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. None of the companies in this report have paid to be included in this report. From time to time we will mention a company that may have previously paid $995 per month for market data purchased from BUYINS.NET. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

BUYINS.NET, FRICTION FACTOR and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of BUYINS.NET, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting BUYINS.NET or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. BUYINS.NET, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to BUYINS.NET and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. BUYINS.NET does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. BUYINS.NET places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.BUYINS.net +1-800-715-9999 Tom@buyins.net